The Schizophrenia-Related Protein Dysbindin-1A Is Degraded and Facilitates NF-Kappa B Activity in the Nucleus

PLoS One. 2015 Jul 14;10(7):e0132639. doi: 10.1371/journal.pone.0132639. eCollection 2015.

Abstract

Dystrobrevin-binding protein 1 (DTNBP1), a gene encoding dysbindin-1, has been identified as a susceptibility gene for schizophrenia. Functioning with partners in synapses or the cytoplasm, this gene regulates neurite outgrowth and neurotransmitter release. Loss of dysbindin-1 affects schizophrenia pathology. Dysbindin-1 is also found in the nucleus, however, the characteristics of dysbindin in the nucleus are not fully understood. Here, we found that dysbindin-1A is degraded in the nucleus via the ubiquitin-proteasome system and that amino acids 2-41 at the N-terminus are required for this process. By interacting with p65, dysbindin-1A promotes the transcriptional activity of NF-kappa B in the nucleus and positively regulates MMP-9 expression. Taken together, the data obtained in this study demonstrate that dysbindin-1A protein levels are highly regulated in the nucleus and that dysbindin-1A regulates transcription factor NF-kappa B activity to promote the expression of MMP-9 and TNF-α.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Nucleus / metabolism*
  • Dysbindin
  • Dystrophin-Associated Proteins / chemistry
  • Dystrophin-Associated Proteins / metabolism*
  • Gene Expression Regulation, Enzymologic
  • HEK293 Cells
  • Humans
  • Matrix Metalloproteinase 9 / genetics
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • Proteasome Endopeptidase Complex / metabolism
  • Proteolysis*
  • Schizophrenia / metabolism*
  • Transcription, Genetic
  • Tumor Necrosis Factor-alpha / genetics
  • Ubiquitin / metabolism

Substances

  • DTNBP1 protein, human
  • Dysbindin
  • Dystrophin-Associated Proteins
  • NF-kappa B
  • Tumor Necrosis Factor-alpha
  • Ubiquitin
  • Matrix Metalloproteinase 9
  • Proteasome Endopeptidase Complex

Grants and funding

The National High-tech Research and Development program of China 973-projects (2012CB947602, http://www.most.gov.cn/), the National Natural Sciences Foundation of China (Nos. 31330030 and 81371393, http://www.nsfc.gov.cn/) and Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases (BM2013003, http://www.jstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.